24/7 Wall St. on MSN
Abbott Labs vs. Pfizer: Which discounted healthcare titan screens as the bigger value trap?
Quick ReadAbbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs a 7% yield with a ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug ...
Zai Lab (ZLAB) and Pfizer (PFE) announced a strategic collaboration for the novel antibacterial drug Xacduro in mainland China. Pfizer’s affiliated companies will be exclusively authorized to ...
Zai Lab and Pfizer Inc. are teaming up in China to fight the deadly carbapenem-resistant Acinetobacter baumannii (CRAB) infection with novel antibacterial drug Xacduro (sulbactam-durlobactam). Through ...
Cancer care is on the cusp of a revolution, and we recently sat down with Chris Boshoff, M.D., Ph.D., Chief Development Officer, Oncology and Rare Disease, Pfizer Global Product Development, to ...
GROTON, Conn. (WTNH) — Counterfeit Medicine is a growing global threat. At Pfizer, a dedicated team is leading the fight to stop these dangerous fakes. CT Buzz reporter Jillian Andrews visited ...
At a time when funding is scarce and it seems like more local life science companies are laying off or moving out of California, there are still opportunities being built for San Diego’s biotech ...
4mon
Telescope Innovations Installs Second Self-Driving Lab at Pfizer, Advancing Physical AI Deployment
Detailed price information for Telescope Innovations Cp (TELIF) from The Globe and Mail including charting and trades.
U.S. FDA expands approval of HYMPAVZI for pediatric hemophilia A and B patients. Label now includes children as young as six, with and without inhibitors. First subcutaneous non factor therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results